A., Lopes, M
Exclusion criteria in studies typically include Wilson's disease, copper allergy, and pregnancy due to insufficient data in those populations
If youre using this type, you might maintain good levels with just 0.3mL weekly while others need 0.5mL of different types
METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
Packaging Compatibility, Labeling Requirements, and Global Compliance Another area I pay close attention to is how well the manufacturer understands packaging compatibility and labeling requirements